STTCOMP BOT, TA LONG Botanix Pharmaceuticals MC $85m Cash $15m...

STTCOMP BOT, TA LONG​

Botanix Pharmaceuticals​

MC $85m​

Cash $15m​

Botanix develops therapeutics for treatment of skin diseases. ​

It uses a proprietary drug delivery system (Permetrex) for direct skin delivery of pharmaceuticals, and has a pipeline of Permetrex enabled products.​

In Q2 BOT will commence Phase 2 Acne Trials, and receive results for Phase 1B Dermatitis trials.​

Minervini tip number 2 (TGN, BOT)​

Last 3 months has seen the construction of Base 2, which saw declining volumes throughout.​

Retracements throughout Base 2 reduced from 25% to 14%.​

Not really any shakeouts throughout the building of the base however.​

Breakout on volume today. Buy price 14 cents. Stop loss 13 cents.​

Don't think I've ever cheered for a BOT before.​

​